This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more highlights of prescribing information - Takeda
In 2015, Takeda Pharmaceuticals agreed to a massive $2.37 billion settlement to resolve approximately 9,000 bladder cancer claims in the U.S..
Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer. ACTOS CANCER
While the drug remains on the market in the U.S., the FDA prescribing information now includes warnings about the potential bladder cancer risk. 3. Warning Signs and Symptoms
In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug. This is for informational purposes only
If you or a loved one have taken Actos, medical professionals advise monitoring for symptoms of bladder cancer, which include:
Check your records to see how long you took Actos and at what dosage. Learn more highlights of prescribing information - Takeda
, such as needing to urinate more frequently or urgently. Pain during urination (dysuria). Pain in the lower back or pelvic region . 4. Legal Status and Claims
